Growth-oriented stocks have faced serious headwinds lately, and the volatility may continue well into 2023. However, for investors in it for the long haul, great companies with clear paths to future growth abound, even in the current market.

If you have spare cash to put to work to build your portfolio right now, here are two fantastic growth stocks in the healthcare space that you may want to consider adding to your buy list before the end of January.

Vertex Pharmaceuticals (NASDAQ: VRTX) has largely eluded the trends driving the broader market over the last year. In fact, while the S&P 500 has delivered a negative return of 18% over the trailing 12 months, Vertex Pharmaceuticals boasts a trailing-12-month return of approximately 30%. 

Continue reading

Source Fool.com